Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ADI-AAS-070-E - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ADI-AAS-070-E, RRID:AB_2038862
- Product name
- Bcl-2 polyclonal antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Protein A affinity purified.
- Reactivity
- Human, Simian
- Host
- Rabbit
- Vial size
- 100 μg
- Storage
- -20°C
- Handling
- Avoid freeze/thaw cycles.
Submitted references NaCl induced high cationic hydroxyethylated cholesterol-based nanoparticle-mediated synthetic small interfering RNA transfer into prostate carcinoma PC-3 cells.
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Hattori Y, Yoshizawa T, Koga K, Maitani Y
Biological & pharmaceutical bulletin 2008 Dec;31(12):2294-301
Biological & pharmaceutical bulletin 2008 Dec;31(12):2294-301
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C
Cancer research 2002 Aug 15;62(16):4592-8
Cancer research 2002 Aug 15;62(16):4592-8
No comments: Submit comment
Supportive validation
- Submitted by
- Enzo Life Sciences (provider)
- Main image
- Experimental details
- Western blot analysis of monkey Vero cell lysate probed with Bcl-2 pAb.